Inhibitory activity and protein binding of L-lysine derivatives as angiotensin converting enzyme inhibitors.
Four compounds 1a-4a containing one L-lysine residue in the molecule including a diastereomer mixture of lisinopril (N-(1-carboxy-3-phenylpropyl)-L-lysyl-L-proline) and N epsilon-carbobenzoxy-L-lysine derivatives 1b-4b of each of the four compounds were synthesized to compare the angiotensin converting enzyme (ACE) inhibitory activities in vitro and in vivo. They all showed high ACE inhibitory activity in vitro (IC50 = 0.14-42 nmol/l). A marked difference, however, was observed in inhibition of the pressor response to angiotensin I between 1a-4a (high activity) and 1b-4b (low activity). The binding of these compounds to human serum proteins in vitro was investigated by means of equilibrium dialysis and ultracentrifugation. Compounds 1b-4b showed higher levels of binding to serum albumin than that of the corresponding compounds 1a-4a, and the percentage of binding ranged from 20.1 to 89.1%. Furthermore, the inhibitory activity of compounds 1b-4b in vitro was decreased by the addition of albumin in a concentration-dependent manner. These results suggested that the difference in the protein binding rate of compounds is one of the important factors influencing the inhibitory activity in vivo.
Saito
S
S
Central Research Laboratories, Asahi Breweries, Ltd., Tokyo, Japan.
Matsui
S
S
Watanabe
M
M
Waga
T
T
Kajiwara
Y
Y
Shirota
M
M
Iijima
M
M
Kitabatake
K
K
Matsushita
Y
Y
Moriguchi
I
I
D000806:Angiotensin-Converting Enzyme Inhibitors; D000818:Animals; D001798:Blood Proteins / Q000378:metabolism; D003956:Dialysis; D004656:Enalapril / Q000031:analogs & derivatives / Q000494:pharmacology; D006801:Humans; D017706:Lisinopril; D008239:Lysine / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology*; D008297:Male; D011485:Protein Binding; D011817:Rabbits; D051381:Rats; D011919:Rats, Inbred Strains; D012709:Serum Albumin / Q000378:metabolism; D013237:Stereoisomerism; D014461:Ultracentrifugation
D000806:Angiotensin-Converting Enzyme Inhibitors; D001798:Blood Proteins; D012709:Serum Albumin; D004656:Enalapril; D017706:Lisinopril; D008239:Lysine